Pelargonium Graveolens (Geranium) for Wound Healing

Research suggests that Pelargonium graveolens (rose geranium) has been explored in limited laboratory and clinical contexts with potential relevance to wound healing, though the direct evidence base is narrow. A 2017 in vitro study examined essential oils on human skin fibroblasts in a chronic inflammation model, finding that several oils influenced proteins involved in inflammation and tissue remodeling, with findings that the authors described as suggestive of wound-healing potential; however, Pelargonium graveolens was not among the primary oils highlighted for these effects. A 2012 randomized controlled trial investigated a multi-herb complex containing rose geranium alongside other botanicals in breast cancer patients, finding some protective effects on immune cells during treatment, though this study was not designed to assess wound healing and the contribution of geranium specifically cannot be isolated from the blend. Taken together, the available evidence is preliminary and indirect, consisting of one in vitro study and one clinical trial studying geranium only as part of a multi-ingredient formula, making it difficult to draw conclusions about geranium's role in wound healing on its own.